Literature DB >> 31336394

Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH-HCC guidelines) 2019 update.

Norihiro Kokudo1, Nobuyuki Takemura1, Kiyoshi Hasegawa1, Tadatoshi Takayama1, Shoji Kubo1, Mitsuo Shimada1, Hiroaki Nagano1, Etsuro Hatano1, Namiki Izumi1, Shuichi Kaneko1, Masatoshi Kudo1, Hiroko Iijima1, Takuya Genda1, Ryosuke Tateishi1, Takuji Torimura1, Hiroshi Igaki1, Satoshi Kobayashi1, Hideyuki Sakurai1, Takamichi Murakami1, Takeyuki Watadani1, Yutaka Matsuyama1.   

Abstract

The fourth version of Clinical Practice Guidelines for Hepatocellular Carcinoma was revised by the Japan Society of Hepatology, according to the methodology of evidence-based medicine and partly to the Grading of Recommendations Assessment, Development, and Evaluation system, which was published in October 2017 in Japanese. New or revised recommendations were described, herein, with a special reference to the surveillance, diagnostic, and treatment algorithms.
© 2019 The Japan Society of Hepatology.

Entities:  

Keywords:  algorithm for surveillance and diagnosis; algorithm for treatment; clinical practice guidelines; hepatocellular carcinoma

Year:  2019        PMID: 31336394     DOI: 10.1111/hepr.13411

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  114 in total

1.  Reply to the Letter "Comment on Regarding Manuscript 'Treatment of Intermediate Stage Hepatocellular Carcinoma in Japan: Position of Curative Therapies'".

Authors:  Kazuhiro Nouso; Kazuya Kariyama
Journal:  Liver Cancer       Date:  2021-03-11       Impact factor: 11.740

2.  What liver surgeons have achieved in the recent decade for patients with hepatocellular carcinoma?

Authors:  Takashi Kokudo; Norihiro Kokudo
Journal:  Glob Health Med       Date:  2020-10-31

Review 3.  Optimal Modalities for HCC Surveillance in a High-Incidence Region.

Authors:  Young Chang; Jeong-Hoon Lee
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-01-13

4.  Predictors for Grip Strength Loss in Patients With Chronic Liver Diseases.

Authors:  Hiroki Nishikawa; Kazunori Yoh; Hirayuki Enomoto; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Takashi Nishimura; Shuhei Nishiguchi; Hiroko Iijima
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.155

5.  The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease.

Authors:  Mohammed Eslam; Shiv K Sarin; Vincent Wai-Sun Wong; Jian-Gao Fan; Takumi Kawaguchi; Sang Hoon Ahn; Ming-Hua Zheng; Gamal Shiha; Yusuf Yilmaz; Rino Gani; Shahinul Alam; Yock Young Dan; Jia-Horng Kao; Saeed Hamid; Ian Homer Cua; Wah-Kheong Chan; Diana Payawal; Soek-Siam Tan; Tawesak Tanwandee; Leon A Adams; Manoj Kumar; Masao Omata; Jacob George
Journal:  Hepatol Int       Date:  2020-10-01       Impact factor: 6.047

Review 6.  Recent Advances in Systemic Therapy for Hepatocellular Carcinoma in an Aging Society: 2020 Update.

Authors:  Masatoshi Kudo
Journal:  Liver Cancer       Date:  2020-11-17       Impact factor: 11.740

7.  Early hemodynamics of hepatocellular carcinoma using contrast-enhanced ultrasound with Sonazoid: focus on the pure arterial and early portal phases.

Authors:  Akiko Saito; Masakazu Yamamoto; Satoshi Katagiri; Shingo Yamashita; Masayuki Nakano; Toshio Morizane
Journal:  Glob Health Med       Date:  2020-10-31

Review 8.  Hepatocyte ploidy and pathological mutations in hepatocellular carcinoma: impact on oncogenesis and therapeutics.

Authors:  Taiji Yamazoe; Taizo Mori; Sachiyo Yoshio; Tatsuya Kanto
Journal:  Glob Health Med       Date:  2020-10-31

Review 9.  Difference in treatment algorithms for hepatocellular carcinoma between world's principal guidelines.

Authors:  Kyoji Ito; Nobuyuki Takemura; Fuyuki Inagaki; Fuminori Mihara; Norihiro Kokudo
Journal:  Glob Health Med       Date:  2020-10-31

Review 10.  Does Hepatocellular Carcinoma Surveillance Increase Survival in At-Risk Populations? Patient Selection, Biomarkers, and Barriers.

Authors:  Lisa X Deng; Neil Mehta
Journal:  Dig Dis Sci       Date:  2020-12       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.